Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection

NCT03788434 is registered in ClinicalTrials.gov with Vedanta Biosciences, Inc. as lead sponsor.

NCT NCT03788434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
Lead sponsor
Vedanta Biosciences, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 8, 2019
Completion date
September 15, 2021
Enrollment
79 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

cdi, clostridioides difficile, clostridioides difficile infection, clostridioides difficile infection recurrence, clostridium difficile, clostridium difficile infection, clostridium difficile infection recurrence